3-cyclohexyl-N-methylaniline;N-ethyl-N-methyl-3-(methylamino)benzenesulfonamide;2-[N-ethylsulfonyl-3-(methylamino)anilino]-N,N-dimethylacetamide;3-(1H-imidazol-5-yl)-N-methylaniline;1-[3-(methylamino)phenyl]imidazolidin-2-one;2-[3-(methylamino)phenyl]sulfonylethanol;N-methyl-3-(methylamino)benzamide;1-methyl-3-[3-(methylamino)phenyl]imidazolidin-2-one;N-methyl-3-(2-methylpyrimidin-4-yl)aniline;N-methyl-3-piperidin-1-ylsulfonylaniline

C109H151N23O13S4 — CID 158178486

IUPAC3-cyclohexyl-N-methylaniline;N-ethyl-N-methyl-3-(methylamino)benzenesulfonamide;2-[N-ethylsulfonyl-3-(methylamino)anilino]-N,N-dimethylacetamide;3-(1H-imidazol-5-yl)-N-methylaniline;1-[3-(methylamino)phenyl]imidazolidin-2-one;2-[3-(methylamino)phenyl]sulfonylethanol;N-methyl-3-(methylamino)benzamide;1-methyl-3-[3-(methylamino)phenyl]imidazolidin-2-one;N-methyl-3-(2-methylpyrimidin-4-yl)aniline;N-methyl-3-piperidin-1-ylsulfonylaniline
SMILESCCN(C)S(=O)(=O)c1cccc(NC)c1.CCS(=O)(=O)N(CC(=O)N(C)C)c1cccc(NC)c1.CNC(=O)c1cccc(NC)c1.CNc1cccc(-c2ccnc(C)n2)c1.CNc1cccc(-c2cnc[nH]2)c1.CNc1cccc(C2CCCCC2)c1.CNc1cccc(N2CCN(C)C2=O)c1.CNc1cccc(N2CCNC2=O)c1.CNc1cccc(S(=O)(=O)CCO)c1.CNc1cccc(S(=O)(=O)N2CCCCC2)c1
InChIInChI=1S/C13H21N3O3S.C13H19N.C12H13N3.C12H18N2O2S.C11H15N3O.C10H13N3O.C10H11N3.C10H16N2O2S.C9H12N2O.C9H13NO3S/c1-5-20(18,19)16(10-13(17)15(3)4)12-8-6-7-11(9-12)14-2;1-14-13-9-5-8-12(10-13)11-6-3-2-4-7-11;1-9-14-7-6-12(15-9)10-4-3-5-11(8-10)13-2;1-13-11-6-5-7-12(10-11)17(15,16)14-8-3-2-4-9-14;1-12-9-4-3-5-10(8-9)14-7-6-13(2)11(14)15;1-11-8-3-2-4-9(7-8)13-6-5-12-10(13)14;1-11-9-4-2-3-8(5-9)10-6-12-7-13-10;1-4-12(3)15(13,14)10-7-5-6-9(8-10)11-2;1-10-8-5-3-4-7(6-8)9(12)11-2;1-10-8-3-2-4-9(7-8)14(12,13)6-5-11/h6-9,14H,5,10H2,1-4H3;5,8-11,14H,2-4,6-7H2,1H3;3-8,13H,1-2H3;5-7,10,13H,2-4,8-9H2,1H3;3-5,8,12H,6-7H2,1-2H3;2-4,7,11H,5-6H2,1H3,(H,12,14);2-7,11H,1H3,(H,12,13);5-8,11H,4H2,1-3H3;3-6,10H,1-2H3,(H,11,12);2-4,7,10-11H,5-6H2,1H3
InChIKeyFYHBRNDUNOJVAH-UHFFFAOYSA-N
MW2119.82 g/mol
LogP17.07
Rot. Bonds29

About 3-cyclohexyl-N-methylaniline;N-ethyl-N-methyl-3-(methylamino)benzenesulfonamide;2-[N-ethylsulfonyl-3-(methylamino)anilino]-N,N-dimethylacetamide;3-(1H-imidazol-5-yl)-N-methylaniline;1-[3-(methylamino)phenyl]imidazolidin-2-one;2-[3-(methylamino)phenyl]sulfonylethanol;N-methyl-3-(methylamino)benzamide;1-methyl-3-[3-(methylamino)phenyl]imidazolidin-2-one;N-methyl-3-(2-methylpyrimidin-4-yl)aniline;N-methyl-3-piperidin-1-ylsulfonylaniline

3-cyclohexyl-N-methylaniline;N-ethyl-N-methyl-3-(methylamino)benzenesulfonamide;2-[N-ethylsulfonyl-3-(methylamino)anilino]-N,N-dimethylacetamide;3-(1H-imidazol-5-yl)-N-methylaniline;1-[3-(methylamino)phenyl]imidazolidin-2-one;2-[3-(methylamino)phenyl]sulfonylethanol;N-methyl-3-(methylamino)benzamide;1-methyl-3-[3-(methylamino)phenyl]imidazolidin-2-one;N-methyl-3-(2-methylpyrimidin-4-yl)aniline;N-methyl-3-piperidin-1-ylsulfonylaniline (PubChem CID 158178486) has the molecular formula C109H151N23O13S4 and a molecular weight of 2119.82 g/mol. Its IUPAC name is 3-cyclohexyl-N-methylaniline;N-ethyl-N-methyl-3-(methylamino)benzenesulfonamide;2-[N-ethylsulfonyl-3-(methylamino)anilino]-N,N-dimethylacetamide;3-(1H-imidazol-5-yl)-N-methylaniline;1-[3-(methylamino)phenyl]imidazolidin-2-one;2-[3-(methylamino)phenyl]sulfonylethanol;N-methyl-3-(methylamino)benzamide;1-methyl-3-[3-(methylamino)phenyl]imidazolidin-2-one;N-methyl-3-(2-methylpyrimidin-4-yl)aniline;N-methyl-3-piperidin-1-ylsulfonylaniline.

Molecular Properties

Compound Name3-cyclohexyl-N-methylaniline;N-ethyl-N-methyl-3-(methylamino)benzenesulfonamide;2-[N-ethylsulfonyl-3-(methylamino)anilino]-N,N-dimethylacetamide;3-(1H-imidazol-5-yl)-N-methylaniline;1-[3-(methylamino)phenyl]imidazolidin-2-one;2-[3-(methylamino)phenyl]sulfonylethanol;N-methyl-3-(methylamino)benzamide;1-methyl-3-[3-(methylamino)phenyl]imidazolidin-2-one;N-methyl-3-(2-methylpyrimidin-4-yl)aniline;N-methyl-3-piperidin-1-ylsulfonylaniline
PubChem CID158178486
Molecular FormulaC109H151N23O13S4
Molecular Weight2119.82 g/mol
Exact Mass2118.07
IUPAC Name3-cyclohexyl-N-methylaniline;N-ethyl-N-methyl-3-(methylamino)benzenesulfonamide;2-[N-ethylsulfonyl-3-(methylamino)anilino]-N,N-dimethylacetamide;3-(1H-imidazol-5-yl)-N-methylaniline;1-[3-(methylamino)phenyl]imidazolidin-2-one;2-[3-(methylamino)phenyl]sulfonylethanol;N-methyl-3-(methylamino)benzamide;1-methyl-3-[3-(methylamino)phenyl]imidazolidin-2-one;N-methyl-3-(2-methylpyrimidin-4-yl)aniline;N-methyl-3-piperidin-1-ylsulfonylaniline
SMILESCCN(C)S(=O)(=O)c1cccc(NC)c1.CCS(=O)(=O)N(CC(=O)N(C)C)c1cccc(NC)c1.CNC(=O)c1cccc(NC)c1.CNc1cccc(-c2ccnc(C)n2)c1.CNc1cccc(-c2cnc[nH]2)c1.CNc1cccc(C2CCCCC2)c1.CNc1cccc(N2CCN(C)C2=O)c1.CNc1cccc(N2CCNC2=O)c1.CNc1cccc(S(=O)(=O)CCO)c1.CNc1cccc(S(=O)(=O)N2CCCCC2)c1
InChIInChI=1S/C13H21N3O3S.C13H19N.C12H13N3.C12H18N2O2S.C11H15N3O.C10H13N3O.C10H11N3.C10H16N2O2S.C9H12N2O.C9H13NO3S/c1-5-20(18,19)16(10-13(17)15(3)4)12-8-6-7-11(9-12)14-2;1-14-13-9-5-8-12(10-13)11-6-3-2-4-7-11;1-9-14-7-6-12(15-9)10-4-3-5-11(8-10)13-2;1-13-11-6-5-7-12(10-11)17(15,16)14-8-3-2-4-9-14;1-12-9-4-3-5-10(8-9)14-7-6-13(2)11(14)15;1-11-8-3-2-4-9(7-8)13-6-5-12-10(13)14;1-11-9-4-2-3-8(5-9)10-6-12-7-13-10;1-4-12(3)15(13,14)10-7-5-6-9(8-10)11-2;1-10-8-5-3-4-7(6-8)9(12)11-2;1-10-8-3-2-4-9(7-8)14(12,13)6-5-11/h6-9,14H,5,10H2,1-4H3;5,8-11,14H,2-4,6-7H2,1H3;3-8,13H,1-2H3;5-7,10,13H,2-4,8-9H2,1H3;3-5,8,12H,6-7H2,1-2H3;2-4,7,11H,5-6H2,1H3,(H,12,14);2-7,11H,1H3,(H,12,13);5-8,11H,4H2,1-3H3;3-6,10H,1-2H3,(H,11,12);2-4,7,10-11H,5-6H2,1H3
InChIKeyFYHBRNDUNOJVAH-UHFFFAOYSA-N
XLogP17.07
TPSA446.57 Ų
H-Bond Donors14
H-Bond Acceptors26
Rotatable Bonds29
Heavy Atoms149
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002119.82
LogP ≤ 517.07
H-Bond Donors ≤ 514
H-Bond Acceptors ≤ 1026

Analyze 3-cyclohexyl-N-methylaniline;N-ethyl-N-methyl-3-(methylamino)benzenesulfonamide;2-[N-ethylsulfonyl-3-(methylamino)anilino]-N,N-dimethylacetamide;3-(1H-imidazol-5-yl)-N-methylaniline;1-[3-(methylamino)phenyl]imidazolidin-2-one;2-[3-(methylamino)phenyl]sulfonylethanol;N-methyl-3-(methylamino)benzamide;1-methyl-3-[3-(methylamino)phenyl]imidazolidin-2-one;N-methyl-3-(2-methylpyrimidin-4-yl)aniline;N-methyl-3-piperidin-1-ylsulfonylaniline with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 3-cyclohexyl-N-methylaniline;N-ethyl-N-methyl-3-(methylamino)benzenesulfonamide;2-[N-ethylsulfonyl-3-(methylamino)anilino]-N,N-dimethylacetamide;3-(1H-imidazol-5-yl)-N-methylaniline;1-[3-(methylamino)phenyl]imidazolidin-2-one;2-[3-(methylamino)phenyl]sulfonylethanol;N-methyl-3-(methylamino)benzamide;1-methyl-3-[3-(methylamino)phenyl]imidazolidin-2-one;N-methyl-3-(2-methylpyrimidin-4-yl)aniline;N-methyl-3-piperidin-1-ylsulfonylaniline?
The IUPAC name of 3-cyclohexyl-N-methylaniline;N-ethyl-N-methyl-3-(methylamino)benzenesulfonamide;2-[N-ethylsulfonyl-3-(methylamino)anilino]-N,N-dimethylacetamide;3-(1H-imidazol-5-yl)-N-methylaniline;1-[3-(methylamino)phenyl]imidazolidin-2-one;2-[3-(methylamino)phenyl]sulfonylethanol;N-methyl-3-(methylamino)benzamide;1-methyl-3-[3-(methylamino)phenyl]imidazolidin-2-one;N-methyl-3-(2-methylpyrimidin-4-yl)aniline;N-methyl-3-piperidin-1-ylsulfonylaniline (CID 158178486) is 3-cyclohexyl-N-methylaniline;N-ethyl-N-methyl-3-(methylamino)benzenesulfonamide;2-[N-ethylsulfonyl-3-(methylamino)anilino]-N,N-dimethylacetamide;3-(1H-imidazol-5-yl)-N-methylaniline;1-[3-(methylamino)phenyl]imidazolidin-2-one;2-[3-(methylamino)phenyl]sulfonylethanol;N-methyl-3-(methylamino)benzamide;1-methyl-3-[3-(methylamino)phenyl]imidazolidin-2-one;N-methyl-3-(2-methylpyrimidin-4-yl)aniline;N-methyl-3-piperidin-1-ylsulfonylaniline.
What is the SMILES notation for 3-cyclohexyl-N-methylaniline;N-ethyl-N-methyl-3-(methylamino)benzenesulfonamide;2-[N-ethylsulfonyl-3-(methylamino)anilino]-N,N-dimethylacetamide;3-(1H-imidazol-5-yl)-N-methylaniline;1-[3-(methylamino)phenyl]imidazolidin-2-one;2-[3-(methylamino)phenyl]sulfonylethanol;N-methyl-3-(methylamino)benzamide;1-methyl-3-[3-(methylamino)phenyl]imidazolidin-2-one;N-methyl-3-(2-methylpyrimidin-4-yl)aniline;N-methyl-3-piperidin-1-ylsulfonylaniline?
The canonical SMILES for 3-cyclohexyl-N-methylaniline;N-ethyl-N-methyl-3-(methylamino)benzenesulfonamide;2-[N-ethylsulfonyl-3-(methylamino)anilino]-N,N-dimethylacetamide;3-(1H-imidazol-5-yl)-N-methylaniline;1-[3-(methylamino)phenyl]imidazolidin-2-one;2-[3-(methylamino)phenyl]sulfonylethanol;N-methyl-3-(methylamino)benzamide;1-methyl-3-[3-(methylamino)phenyl]imidazolidin-2-one;N-methyl-3-(2-methylpyrimidin-4-yl)aniline;N-methyl-3-piperidin-1-ylsulfonylaniline is CCN(C)S(=O)(=O)c1cccc(NC)c1.CCS(=O)(=O)N(CC(=O)N(C)C)c1cccc(NC)c1.CNC(=O)c1cccc(NC)c1.CNc1cccc(-c2ccnc(C)n2)c1.CNc1cccc(-c2cnc[nH]2)c1.CNc1cccc(C2CCCCC2)c1.CNc1cccc(N2CCN(C)C2=O)c1.CNc1cccc(N2CCNC2=O)c1.CNc1cccc(S(=O)(=O)CCO)c1.CNc1cccc(S(=O)(=O)N2CCCCC2)c1.
What is the InChIKey of 3-cyclohexyl-N-methylaniline;N-ethyl-N-methyl-3-(methylamino)benzenesulfonamide;2-[N-ethylsulfonyl-3-(methylamino)anilino]-N,N-dimethylacetamide;3-(1H-imidazol-5-yl)-N-methylaniline;1-[3-(methylamino)phenyl]imidazolidin-2-one;2-[3-(methylamino)phenyl]sulfonylethanol;N-methyl-3-(methylamino)benzamide;1-methyl-3-[3-(methylamino)phenyl]imidazolidin-2-one;N-methyl-3-(2-methylpyrimidin-4-yl)aniline;N-methyl-3-piperidin-1-ylsulfonylaniline?
The InChIKey is FYHBRNDUNOJVAH-UHFFFAOYSA-N. The full InChI is InChI=1S/C13H21N3O3S.C13H19N.C12H13N3.C12H18N2O2S.C11H15N3O.C10H13N3O.C10H11N3.C10H16N2O2S.C9H12N2O.C9H13NO3S/c1-5-20(18,19)16(10-13(17)15(3)4)12-8-6-7-11(9-12)14-2;1-14-13-9-5-8-12(10-13)11-6-3-2-4-7-11;1-9-14-7-6-12(15-9)10-4-3-5-11(8-10)13-2;1-13-11-6-5-7-12(10-11)17(15,16)14-8-3-2-4-9-14;1-12-9-4-3-5-10(8-9)14-7-6-13(2)11(14)15;1-11-8-3-2-4-9(7-8)13-6-5-12-10(13)14;1-11-9-4-2-3-8(5-9)10-6-12-7-13-10;1-4-12(3)15(13,14)10-7-5-6-9(8-10)11-2;1-10-8-5-3-4-7(6-8)9(12)11-2;1-10-8-3-2-4-9(7-8)14(12,13)6-5-11/h6-9,14H,5,10H2,1-4H3;5,8-11,14H,2-4,6-7H2,1H3;3-8,13H,1-2H3;5-7,10,13H,2-4,8-9H2,1H3;3-5,8,12H,6-7H2,1-2H3;2-4,7,11H,5-6H2,1H3,(H,12,14);2-7,11H,1H3,(H,12,13);5-8,11H,4H2,1-3H3;3-6,10H,1-2H3,(H,11,12);2-4,7,10-11H,5-6H2,1H3.
What are the key properties of 3-cyclohexyl-N-methylaniline;N-ethyl-N-methyl-3-(methylamino)benzenesulfonamide;2-[N-ethylsulfonyl-3-(methylamino)anilino]-N,N-dimethylacetamide;3-(1H-imidazol-5-yl)-N-methylaniline;1-[3-(methylamino)phenyl]imidazolidin-2-one;2-[3-(methylamino)phenyl]sulfonylethanol;N-methyl-3-(methylamino)benzamide;1-methyl-3-[3-(methylamino)phenyl]imidazolidin-2-one;N-methyl-3-(2-methylpyrimidin-4-yl)aniline;N-methyl-3-piperidin-1-ylsulfonylaniline?
3-cyclohexyl-N-methylaniline;N-ethyl-N-methyl-3-(methylamino)benzenesulfonamide;2-[N-ethylsulfonyl-3-(methylamino)anilino]-N,N-dimethylacetamide;3-(1H-imidazol-5-yl)-N-methylaniline;1-[3-(methylamino)phenyl]imidazolidin-2-one;2-[3-(methylamino)phenyl]sulfonylethanol;N-methyl-3-(methylamino)benzamide;1-methyl-3-[3-(methylamino)phenyl]imidazolidin-2-one;N-methyl-3-(2-methylpyrimidin-4-yl)aniline;N-methyl-3-piperidin-1-ylsulfonylaniline has a molecular weight of 2119.82 g/mol, XLogP of 17.07, 29 rotatable bonds, 14 hydrogen bond donors, and 26 hydrogen bond acceptors.
Where does this data come from?
All data for 3-cyclohexyl-N-methylaniline;N-ethyl-N-methyl-3-(methylamino)benzenesulfonamide;2-[N-ethylsulfonyl-3-(methylamino)anilino]-N,N-dimethylacetamide;3-(1H-imidazol-5-yl)-N-methylaniline;1-[3-(methylamino)phenyl]imidazolidin-2-one;2-[3-(methylamino)phenyl]sulfonylethanol;N-methyl-3-(methylamino)benzamide;1-methyl-3-[3-(methylamino)phenyl]imidazolidin-2-one;N-methyl-3-(2-methylpyrimidin-4-yl)aniline;N-methyl-3-piperidin-1-ylsulfonylaniline is sourced from PubChem (CID 158178486), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).